Viewing Study NCT04203693


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2025-12-25 @ 11:21 PM
Study NCT ID: NCT04203693
Status: COMPLETED
Last Update Posted: 2024-07-08
First Post: 2019-12-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
Sponsor: Almirall, S.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module